What is Anika Therapeutics's free cash flow margin?

Anika Therapeutics (ANIK) reported free cash flow margin of 0.9% in Q1 2026.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Anika Therapeutics ANIK Free cash flow margin

Free cash flow margin at other companies

StrykerSYK

18.1%+2.7pp

VericelVCEL

16.3%—

Zimmer Biomet HoldingsZBH

17.3%-1.6pp

Pacira BioSciences, Inc.PCRX

18.1%-4.6pp

BioventusBVS

17.5%+13.2pp

Xtant Medical HoldingsXTNT

6.4%+4.1pp

Other financials

Income statement

See full

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

See full

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

See full

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

See full

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

See full

Net margin-9.8%-4.4pp

Returns & leverage

See full

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Calculated from Anika Therapeutics’s reported figures.

free cash flow/total revenue=0.9%

Based on trailing twelve months.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anika Therapeutics's free cash flow margin?: Anika Therapeutics (ANIK) reported free cash flow margin of 0.9% in Q1 2026.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.